TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 255 filers reported holding TG THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $500,388 | -68.3% | 59,855 | -5.9% | 0.00% | -66.7% |
| Q2 2023 | $1,580,768 | +142.3% | 63,638 | +46.7% | 0.00% | +200.0% |
| Q1 2023 | $652,390 | +101.4% | 43,377 | +27.3% | 0.00% | 0.0% |
| Q1 2022 | $324,000 | -50.0% | 34,081 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $648,000 | -61.4% | 34,081 | -32.4% | 0.00% | -66.7% |
| Q3 2021 | $1,678,000 | -30.9% | 50,435 | -19.4% | 0.00% | -25.0% |
| Q2 2021 | $2,429,000 | -19.5% | 62,608 | 0.0% | 0.00% | -20.0% |
| Q1 2021 | $3,018,000 | -19.2% | 62,608 | -12.7% | 0.01% | -28.6% |
| Q4 2020 | $3,733,000 | +81.7% | 71,756 | -6.5% | 0.01% | +133.3% |
| Q3 2020 | $2,054,000 | +53.1% | 76,768 | +11.5% | 0.00% | +50.0% |
| Q2 2020 | $1,342,000 | +204.3% | 68,870 | +53.7% | 0.00% | +100.0% |
| Q1 2020 | $441,000 | +10.0% | 44,795 | +23.8% | 0.00% | – |
| Q4 2019 | $401,000 | +322.1% | 36,171 | +113.4% | 0.00% | – |
| Q3 2018 | $95,000 | -79.8% | 16,948 | -52.6% | 0.00% | – |
| Q2 2018 | $471,000 | -29.8% | 35,784 | -24.3% | 0.00% | -100.0% |
| Q1 2018 | $671,000 | +75.7% | 47,267 | +1.6% | 0.00% | – |
| Q4 2017 | $382,000 | -30.7% | 46,537 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $551,000 | +435.0% | 46,537 | +353.0% | 0.00% | – |
| Q2 2017 | $103,000 | -80.7% | 10,274 | -80.7% | 0.00% | -100.0% |
| Q3 2015 | $535,000 | -48.9% | 53,123 | -15.8% | 0.00% | -50.0% |
| Q2 2015 | $1,046,000 | +36.6% | 63,060 | +27.4% | 0.00% | 0.0% |
| Q1 2015 | $766,000 | -0.1% | 49,500 | +2.3% | 0.00% | 0.0% |
| Q4 2014 | $767,000 | +149.0% | 48,400 | +67.5% | 0.00% | +100.0% |
| Q3 2014 | $308,000 | +87.8% | 28,900 | +65.1% | 0.00% | – |
| Q2 2014 | $164,000 | -44.8% | 17,500 | -59.4% | 0.00% | -100.0% |
| Q1 2014 | $297,000 | +76.8% | 43,100 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $168,000 | +223.1% | 43,100 | +322.5% | 0.00% | – |
| Q3 2013 | $52,000 | – | 10,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |